One editor tried lip injections -- and here's her story What It Is: Juvederm Volbella XC, a new lip-injection gel that uses a mixture of hyaluronic acid said to last a full year — way longer than ...

Perioral Rhytids Allergan announced that the Food and Drug Administration (FDA) has approved Juvederm Volbella XC for use in lip augmentation and for correction of perioral rhytids (referred to as ...

DALLAS, TX--(Marketwired - October 06, 2016) - Dr. Lori Stetler and Dr. Kristel Polder, of Dallas Center for Dermatology and Aesthetics, are among the first doctors in the United States to perform ...

The FINANCIAL — Allergan plc, on June 1 announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLBELLA XC, for use in the lips for lip ...

Allergan plc (NYSE: AGN) revealed that the FDA has accorded its approval to market JUVÉDERM VOLBELLA XC, for use in the lips for lip augmentation and for correction of perioral rhytids, commonly ...

Hyaluronic acid 15mg/mL, 0.3% w/w lidocaine; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...

The FDA’s approval of Juvéderm Volbella XC for lip augmentation and correcting perioral rhytids in adults was among the most-read articles of the past week on ...

(RTTNews) - Allergan Aesthetics, an AbbVie company (ABBV), announced the FDA approval of JUVÉDERM VOLBELLA XC for improvement of infraorbital hollows in adults over the age of 21. JUVÉDERM VOLBELLA XC ...

What It Is: Juvederm Volbella XC, a new lip-injection gel that uses a mixture of hyaluronic acid said to last a full year — way longer than other injectables on the market. Who Tried It: Marci Robin, ...